New blood test identifies elusive pancreatic cancer way before symptoms appear
New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.
Blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.
Blood test finds early stage pancreatic cancer with 85% accuracy: 4 study notes
A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science Translational Medicine.
Blood Test for Early Pancreatic Cancer Shows Promise
He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second paper, it usually shows that [the test] fails for earl
Blood Test Detects Pancreatic Cancer With 85% Accuracy
MANN, the test developed at OHSU could help save lives Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer
Most pancreatic cancer isn’t caught until it’s late stage — a new blood test could change that
Get pumped! Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for pancreatic cancer,
News Medical on MSN3d
New immune map uncovers key pancreatic cancer insights
Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...
Pancreatic cancer immune map provides clues for precision treatment targeting
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...
Mena FN3d
Pancreatic Ductal Adenocarcinoma Market Set For Significant Expansion By 2032 Delveinsight
LAS VEGAS , NV, UNITED STATES, February 12, 2025 /EINPresswire / -- DelveInsight's“Pancreatic Ductal Adenocarcinoma market Insights, Epidemiology, and Market Forecast-2032” report offers an in ...
New research targets 'Zombie' cells to improve cancer treatment options
Senescent cells, or ‘zombie’ cells, are damaged cancer cells that remain active, making it harder to treat tumors.
Cure Today6d
Pelareorep With Chemo and Tecentriq Shows Acceptable Safety in Metastatic PDAC
Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...